Adi Kozminsky-Atias

Adi Kozminsky-Atias

Auto-generated profile, based on publicly available information

Adi Kozminsky-Atias

Ferring Be’er Tuvia Industrial Zone, Kiryat Malachi, 8310402, Israel

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2011 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
AKAdi Kozminsky‐Atias
Adi Kozminsky‐Atias
NZNoam Zilberberg
Noam Zilberberg
A diverse range of organisms utilize neurotoxins that target specific ion channels and modulate their activity. Typically, toxins are clustered into several multigene families, providing an organism with the upper hand in the never‐ending predator‐prey arms race. Several gene families, including those encoding certain neurotoxins, have been subject to diversifying selection forces, resulting in rapid gene evolution. Here we sought a spatial pattern in the distribution of both diversifying and purifying selection forces common to neurotoxin gene families. Utilizing the mechanistic empirical combination model, we analyzed various toxin families from different phyla affecting various receptors and relying on diverse modes of action. Through this approach, we were able to detect clear correlations between the pharmacological surface of a toxin and rapidly evolving domains, rich in positively selected residues. On the other hand, patches of negatively selected residues were restricted to the nontoxic face of the molecule and most likely help in stabilizing the tertiary structure of the toxin. We thus propose a mutual evolutionary strategy of venomous animals in which adaptive molecular evolution is directed toward the toxin active surface. Furthermore, we propose that the binding domains of unstudied toxins could be readily predicted using evolutionary considerations.—Kozminsky‐Atias, A., Zilberberg, N. Molding the business end of neurotoxins by diversifying evolution. FASEB J. 26, 576–586 (2012). www.fasebj.org

9 February 2024 in BioTechniques
Verified
Journal Article
Open access
JWJohn R White
John R White
SASammina Ahmed
Sammina Ahmed
JAJan Amstrup
Jan Amstrup
PBPetra Bennington
Petra Bennington
ZCZhijie Jey Cheng
Zhijie Jey Cheng
JWJenny Wang
Jenny Wang
The BioPhorum Development Group is an industry collaboration enabling the sharing of common practices for the development of biopharmaceuticals. Bioassays are an important part of an analytical con... Method summary Draft questions were composed by the authors based on prior knowledge of the issues associated with ready-to-use cell use. Questions were further refined through open discussion amon...